|
|
Volumn 7, Issue 5, 2006, Pages 370-
|
|
Combination treatment improves breast-cancer survival.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
PACLITAXEL;
ARTICLE;
BREAST TUMOR;
FEMALE;
HUMAN;
MORTALITY;
SURVIVAL RATE;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
FEMALE;
HUMANS;
PACLITAXEL;
SURVIVAL RATE;
|
|
EID: 33744774946
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(06)70682-9 Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
